In summary, we show that the DNMT inhibitor 5-AZA down-regulates TERT expression in both AML cell lines and primary leukemic cells, and shortens telomere length coupled with telomere dysfunction, DNA damage response and apoptosis. The gene discussed is TERT; the disease is acute myeloid leukemia.